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Background: Test ventilating prior to administration of neuromuscular blockade (NMB) in order to avoid a cannot
intubate-cannot ventilate situation is a classic anesthesia teaching. The primary aim of our study was to show that
facemask ventilation (FMV) after NMB was not inferior to FMV prior to NMB with respect to exhaled gas volumes
before and after their administration.
Methods: This study was approved by the University of Washington Human Subjects Division (Seattle, Washington,
USA). Written informed consent was obtained from all patients. Measurements of tidal volume (Vte) as well as other
respiratory parameters during FMV were made for 60 s after induction of anesthesia and again after NMB. Difficult,
impossible, inadequate, and dead-space only mask ventilation was graded using published definitions. Difficult
intubation was defined as >2 attempts at intubation. The primary outcome was non-inferiority in Vte during both
study periods defined as a mean difference of <50 mL. Multivariate analysis was performed to assess for interaction
between operator experience, patient risk factors for difficult mask ventilation, exhaled volumes, and use of airway
adjuncts.
Results: Two-hundred and ten patients were studied. Overall, FMV improved after NMBD. The mean (SD) Vte in mL/
breath increased from 399 (169) to 428 (166) (mean dif. 30 mL, p = 0.001) and the minute ventilation in L/min from
5.6 (2.5) to 6.3 (2.5) (mean dif. 0.6, p < 0.001). No patient who was difficult to ventilate after induction became
impossible after NMB.
Discussion: In patients at risk for or judged to be a difficult FMV by clinical grading scales, tidal volumes improved
after administration of NMBDs. None of these patients exhibited a decline in ventilation or became impossible to
ventilate after NMBDs. Several limitations are noted, including the use of hand-delivered breaths and inability to
account for time-related changes in ventilation conditions independent of NMBDs.
Conclusion: We conclude that FMV is no worse after NMB than before and is likely to improve airway conditions.
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Facemask ventilation (FMV) is considered the most
basic of airway management skills and the first-line tech-
nique to provide ventilation of the unconscious and ap-
neic patient. While several patient-related factors have
been identified as high-risk features for difficult or im-
possible mask ventilation (DMV or IMV) after induction
of [1–4], whether or not the routine administration of a
neuromuscular blocking drug (NMBD) prior to “testing”
the operators’ ability to ventilate the patient by mask is a
help or a hindrance is debatable [5]. Those who argue
for “testing” the ability to ventilate before administering
NMBD cite concern that complete airway obstruction
from NMBD-induced upper airway collapse could result
in a “cannot intubate-cannot ventilate” situation if tra-
cheal intubation were not possible [6–8]. Still, others
argue that residual muscle tone after the induction of
anaesthesia results in some resistance to mask ventila-
tion that is only interpreted by the operator as DMV [9].
If true, administration of a NMBD just after intravenous
induction agents would facilitate ventilation as well as
allowing earlier identification of patients who will be dif-
ficult or impossible, allowing for more timely interven-
tion to establish an airway. Investigators have reported
either no effect [10] or improvements in mask ventila-
tion difficulty scores [11] and exhaled volumes [12, 13]
after NMBDs have been administered. Notably, none of
these studies have reported deterioration in FMV after
the administration of a NMBD. However, these studies
were designed to demonstrate the superiority of FMV
after NMBD with respect to exhaled volumes and thus,
may have been underpowered to demonstrate clinically
relevant side effects, chiefly, worsening of FMV associ-
ated with hypoxia and/or difficult intubation. Thus, the
primary aim of our study was to demonstrate the non-
inferiority of NMBDs administered to facilitate mask
ventilation with respect to exhaled tidal volumes
measured before and after their administration.
Methods
The trial was registered with ClinicalTrials.gov (identifier
NCT02237443) and approved by the University of Wash-
ington Human Subjects Division (Seattle, Washington,
USA). Written informed consent was obtained from all pa-
tients or their legal surrogate. All adults (≥18 years of age)
were eligible if all of the following conditions were met;
they were scheduled for elective or semi-elective surgery,
induction of general anaesthesia by intravenous propofol
was planned, a tracheal tube was to be placed for airway
maintenance. Patients who had symptomatic reflux, prior
oesophagectomy, hiatal hernia, emesis within 24 h of
surgery, an oropharyngeal or facial pathology making a
proper mask fit unlikely, a prior allergy or contraindication
to receiving rocuronium bromide, vecuronium bromide, orsuccinylcholine chloride, or any condition for which the pri-
mary anaesthesia team deemed a rapid-sequence intubation
to be appropriate, or who were pregnant were excluded.
Patient enrollment was not consecutive, but rather a
convenience sample. A study coordinator and an investi-
gator examined the surgical case list the evening prior to
or on the morning of the planned surgery. An investigator
then informed the anaesthesia team responsible for poten-
tial participants of their patient’s study eligibility. At the
discretion of the primary anaesthesia team, permission
was obtained for the study coordinator to approach the
patient for consent to participate on the day of surgery.
All pre-medications and the doses of intravenous med-
ications given to induce anaesthesia were at the sole dis-
cretion of the primary anaesthesia care team. Once
inside the operating room (OR), standard American So-
ciety of Anesthesiologists (ASA) monitors were estab-
lished. Patients were placed supine, with their head in a
sniffing position using standard pillows. Patients with a
body mass index > 30 kg.m−2 were positioned in a 10 %
or greater head elevated position using the controls of a
standard OR table or wedge. Patients were pre-
oxygenated by tidal breathing 8–10 liters/minute of 100 %
oxygen for a period of 2–3 min. Anaesthesia was induced
with intravenous propofol with or without the concomi-
tant administration of intravenous fentanyl. Use of volatile
agents was allowed. Study measurements began once the
plane of anaesthesia was deep enough to render the pa-
tient unresponsive to a vigorous jaw thrust and the anaes-
thesia provider indicated to the investigator that they were
ready. Depth of anaesthesia monitoring was not used.
Facemask ventilation was performed using a generic
single-handed technique, which incorporated a chin-lift
head-tilt manoeuvre via an appropriately sized adult
facemask (Anaesthesia Face Mask by Vital Signs, Med-
line Industries, Mundelein, IL). An audible metronome
was used to provide a timing prompt in order to achieve
a respiratory rate of 15 breaths per minute with an
inspiratory-to-expiratory ratio of 1-to-1. Per usual care,
providers were instructed to maintain peak airway pres-
sure < 20 cmH2O, as displayed by the pressure manom-
eter on the anaesthesia machine. Use of oro- or
nasopharyngeal airways, two-hand jaw thrust technique
with a second operator squeezing the breathing bag, and
repositioning of the airway to maximise upper airway
patency during each measurement period was at the dis-
cretion of the airway managers; however, an algorithm
for dealing with increasing levels of difficulty with face-
mask ventilation based on typical practice was suggested
(see Additional file 1). Exhaled tidal volumes (Vte) in ml
and peak inspiratory airway pressure (PIP) in cmH2O
were measured using a FloTrak Elite sensor (Phillips
Healthcare, Andover, MD) placed in-line with the anaes-
thesia circuit at the patient wye and attached to a
Fig. 1 Diagrammatic representation of patient flow through
study protocol
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Andover, MD) for display and recording purposes. Data
was stored real-time to a USB storage device and then
imported into Microsoft Excel® for Mac 2011 v14.4.4
(Microsoft Inc., Redmond, WA). At a Vte of 40–2500 ml
and PIP up to 120 cmH2O, the device is accurate to within
the greater of 10 ml or 5 % of the reading and the greater
of 0.5 cmH2O or 2 % of the reading, respectively.
1 Providers
performing the FMV could see the anaesthesia monitor
displaying vital signs, including pulse oximetry (SpO2), end-
tidal carbon dioxide (ETCO2), inhalation anaesthetic
concentration, and pressure manometer of the anaesthesia
machine, but were blinded to inspiratory/expiratory gas
flows. Respiratory data was recorded for one minute after
induction of general anaesthesia (the “before” NMBD study
period). A NMBD was then administered. Recording was
performed for another minute after waiting 60 s post suc-
cinylcholine administration or 90 s post rocuronium or
vecuronium administration, respectively (the “after” NMBD
study period). In accordance with local practice, monitoring
neuromuscular function was not used during induction of an-
aesthesia. Patient flow through the study is shown in Fig. 1.
Difficult and impossible mask ventilation (DMV and
IMV) was defined on the basis of clinical criteria using the
Han’s score [14] and Warters score [11]. Inadequate mask
ventilation (MVi) was defined as an average returned tidal
volume (Vte) of < 4 ml.kg
−1 of predicted body weight
(PBW) while dead-space ventilation (Vds) was defined as
an average returned Vte of < 150 ml.breath
−1 associated
with clinical signs (inadequate chest rise, no fogging in the
mask, no positive tracing of end-tidal carbon dioxide and/
or lack of measurable returned tidal volumes on the an-
aesthesia monitor) [15]. Predicted body weight was calcu-
lated using the National Heart, Lung and Blood Institute
Acute Respiratory Distress Syndrome Network formula.2
Difficult intubation, defined as >2 attempts at intubation
using any technique, was also noted. The study could be
terminated at the discretion of the primary anaesthesia
team if ventilation was inadequate by the above men-
tioned clinical criteria, if the SpO2 was < 90 %, or if the
primary anaesthesia team felt for any reason that immedi-
ate tracheal intubation was needed.
Baseline patient characteristics, including age, sex,
height, weight, and ASA physical status were recorded.
Each participant underwent an independent airway exam
by the study coordinator in addition to that of the primary
anaesthesia team prior to induction. Risk factors for DMV,
including Mallampati grade, presence of facial hair, the
ability to and extent of voluntary mandibular protrusion,
lack of dentition, limited cervical spine motion, or a large
or extremely wasted face were noted. In the event of dis-
cordance between exams, a study investigator adjudicated
findings. The experience/training level of the airway man-
ager was also recorded.Our primary outcome was non-inferiority in the aver-
age Vte per breath (over one minute) during both study
periods defined as a mean difference of <50 ml. Second-
ary outcomes were the difference in total minute ventila-
tion (VE) in l/min (calculated as the sum of all breaths
delivered during each one-minute study period), the oc-
currence f DMV (by Han’s or Warters’ scale), and a
composite of MVi and/or Vds before and after the ad-
ministration of NMBDs.
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At the time of the planning of this study, no studies had
reported a mean (SD) for Vte before and after adminis-
tration of NMBDs. However, based upon a prior com-
parative trial of two different mask-hold techniques15,
the SD of the average Vte after induction of anaesthesia,
using the anaesthesia ventilator and a two-hand jaw-
thrust mask hold technique was 130 ml. With the
equivalence limit, d, set as 50 ml per breath, with a sig-
nificance level (α) of 2.5 % and a power (1-β) of 95 %, a
total sample size of 208 patients per group (before and
after NMBD for a total sample of 416 study periods)
were required. The primary outcome (Vte), as well as
other paired continuous data was compared by paired t-
test or Wilcoxon signed rank test depending on whether
the data were normally distributed. Mean differences are
reported for normally distributed continuous data only.
Paired categorical data were analysed using McNemar’s
test for paired proportions. In order to account for po-
tential confounding of the primary outcome by operator
experience, the number of pre-existing patient risk fac-
tors for DMV, and use of airway adjuncts (a second op-
erator, oral or nasopharyngeal airways), multiple
regression analyses were performed comparing the after
to before measurements adjusting for the characteristics
listed. Because the use of airway adjuncts could differ
between the before and after observations, the unit of
analysis for this model was patient observation, in this
case two observations (before and after) per patient. The
Generalised Estimating Equations approach was used in
computing the regression models, which uses a robust
variance estimator to account for the correlation be-
tween observations from the same patient. The param-
eter of interest is the before-after NMBD covariate.
Data were analysed using R version 2.9.1 (R Founda-
tion for Statistical Computing, Vienna, Austria). Unless
otherwise noted, data are presented as mean (SD), me-
dian (IQR [range]) or frequency (%). Statistical signifi-
cance was defined as a two-sided p-value <0.05.
Results
Two hundred and ten patients were studied (see Fig. 2).
Baseline characteristics and the prevalence of specific
risk factors for DMV in the study population are pre-
sented in Tables 1 and 2. Anaesthesia was induced with
2.13 (0.64) mg.kg−1 of propofol. One hundred and
eighty-six patients also received 1.32 (0.81) mcg.kg−1 of
fentanyl as part of their anaesthetic induction. Paralysis
was induced with 0.6 (0.15) mg.kg−1 of rocuronium in
190 patients, 0.75 (0.25) mg.kg−1 of succinylcholine in
11 patients, and 0.09 (0.02) mg.kg−1 of vecuronium in 9
patients. Fifty-nine individuals provided anaesthesia. Ex-
perience level of the airway mangers and how many
cases they managed are shown in Table 3.The results for primary and secondary outcomes are
presented in Table 4. With respect to the primary out-
come, the average Vte in ml/breath before and after the
administration of a NMBD was 399 (169) and 428 (166)
(mean difference (95 % CI) = 30 (12, 47);p = 0.001). Aver-
age VE was also greater (5.6 (2.5) vs 6.3 (2.5), mean dif-
ference = 0.6 (0.4, 0.9); p < 0.001) after NMBDs.
The proportion of patients in whom an airway ad-
junct/assist was used (oral or nasopharyngeal airways, a
second operator, two-hand jaw thrust technique) was
similar before and after NMBDs (28.5 % versus 30.4 %,
p = 0.34). After adjustment for gender, operator experi-
ence, pre-existing patient risk factors for DMV, and use
of airway adjuncts (a second operator, oral or nasopha-
ryngeal airways), the results were essentially unchanged.
The effect of NMBDs was to increase Vte by 31
ml.breath−1 (95 % Wald CI =13, 48; p = 0.001) and to in-
crease VE by 0.7 l.min
−1 (95 % Wald CI =0.4, 0.9; p <
0.001). No patient suffered oxygen desaturation or <90
% during the study period. No gastric distension was
noted by either auscultation or abdominal distension at
any time during FMV in any of the study patients.
In post-hoc analysis, degradation of FMV was noted in
some patients after the administration of NMBDs. Nine-
teen percent (40/210) of patients had a decrease in Vte
outside of the predetermined equivalence limit of 50ml
(495 (170) before versus 351 (138) after NMBD, mean dif-
ference 82 ml; 95 % CI 57–105, p < 0.001). Although these
patients were slightly older than those in whom FMV did
not degrade after NMBD (46 (17) versus 40 (18) years old,
p = 0.03), sex of the study participants, ASA physical sta-
tus, height, weight, BMI, the number of patients with mul-
tiple risk factors for DMV as well as the overall proportion
of patients with each risk factor, were similar. Further, no
patient who was considered difficult by any of the scales
used became impossible after the administration of
NMBDs. Additionally, among the subgroup of patients
who were initially considered as DMV/IMV or MVi /Vds,
none suffered a degradation in Vte and, overall, the Vte im-
proved significantly after NMBD administration (Table 5).
Three patients (1.4 %) were defined as difficult intubations
(requiring >2 attempts at intubation). All 3 patients were
intubated by the third attempt and none of them were dif-
ficult to hand ventilate before or after administration of
the NMBD.
Discussion
Our main findings are that FMV after administration of
NMBDs is not inferior to FMV after induction alone.
Further, in a pre-defined subgroup of patients in whom
FMV was judged to be difficult by a Han’s score ≥3 or
Warters’ score ≥4, Vte was significantly improved after
administration of NMBDs. Similarly, patients definded
as having inadequate ventilation (Vte < 4 ml.kg
−1 PBW)
Fig. 2 Consort diagram of patient flow through the study
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ventilation after the administration of NMBDs. Import-
antly, none of these patients exhibited a decline in venti-
lation or became impossible to ventilate after NMBDs.
Our findings are consistent with prior investigations
[11–13]. However, only 2 of these studies reported actual
exhaled gas volumes. Ikeda and colleagues reported an in-
crease in tidal volumes from 4.2 (2.1) to 5.4 (2.6) ml.kg−1
(P = 0.02) in 17 patients following succinylcholine admin-
istration [12]. In a larger and more recent trial, Sachdeva
et al. reported that in 125 patients administered rocuro-
nium post-induction, average tidal volumes increased
from 525 (116) ml to 586 (129) ml (p < 0.001) [13]. In con-
trast to our findings, neither of these prior investigations
noted any degradation in ventilation after the administra-
tion of NMBDs. A number of explanations for thisdiscrepancy exist. First, our study was much larger than
any similar prior investigation and has greater power to
detect low frequency events. Second, having a normal air-
way or a history of a difficult airway was not needed for
inclusion or exclusion in our study, respectively. Indeed,
half of our study population had multiple risk factors for
DMV. In particular, approximately one-third of our pa-
tients had a BMI >30 (10 patients had a BMI >40, range
41–53 kg.m−2) and/or a MP grade of >3. Third, in our
study patients’ lungs were hand-ventilated using the
breathing bag of the anaesthesia machine rather than reci-
veing breaths mechanically generated via the anaesthesia
ventilator. Without airway pressures held constant
throughout the respiratory cycle, tidal volumes may have
varied from breath to breath. Use of the anaesthesia venti-
lator to deliver breaths in pressure control mode frees the
Table 1 Baseline characteristics of 210 patients undergoing face
mask ventilation before and after neuromuscular blockade. Data
are presented as number (%), mean (SD), or median (IQR [range])
Age, years 45 (17)
Male gender 135 (64.3)
ASA physical status 2 (1–2[1–4])
Height, cm 173 (13)
Weight, kg 85 (22)
BMI, kg.m−2 27 (23-32[15–53])







ASA American Society of Anesthesiologists, BMI body mass index, DMV difficult
mask ventilation
Table 3 Characteristics of anaesthesia who provided face mask
ventilation to patients before and after neuromuscular blockade.
Data are presened as number (%) or median (IQR [range])
Number of providersntry> 59
Male gender 136 (65)
Finger span, cm 22 (21-23 [17.5-26])








CA clinical anaesthesia training year, CRNA nurse anaesthetists
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maneuvers, which has been documented to result in
greater ventilation than use of a typical left-handed “EC-
clamp” technique [15]. Still, the results of our multivariate
analysis, which adjusted for DMV risk factors, operator
experience, and use of airway adjuncts showed a similar
advantage of NMBDs on FMV, regardless of whether it
was the tidal volume or overall minute ventilation was
considered.
In order for our study to have greater practical appli-
cation to bedside clinicians, we graded the ease of FMV
before and after administration of NMBDs using cur-
rently published definitions in addition to recording ex-
haled gas volumes. We considered the Han, Warters,
and MVi/Vds definitions to be clinical [14], clinico-
physiologic [11], and physiologic [15]. It is interestingTable 2 Prevalence of specific risk factors for difficult mask
ventilation among patients undergoing face mask ventilation
before and after neuromuscular blockade. Data are presented as
number (%)
Age >55 years 70 (33.3)
BMI >30 kg.m−2 71 (33.8)
Mallampati grade ≥3 62 (29.5)
Cannot prognath 14 (6.6)
Facial hair 30 (14.2)
History of snoring or OSA 39 (18.6)
Edentulous 13 (6.2)
Limited cervical spine extension 21 (10)
Large or wasted face 23 (11)
BMI body mass index, DMV difficult mask ventilation, OSA obstructive
sleep apneathat improvement of FMV was noted after administra-
tion of NMBDs with one clinical grading scale (Warters),
but not another (Han). The explanation lies in how each
of the scales is constructed. The Han scale is ordinal,
categorized as grade 1 (easy mask ventilation) to grade 4
(impossible mask ventilation), and is mostly subjective
[14]. There is little difference between a grade 2 (needs
OPA oral or adjuvant with or without NMBDs) and a
grade 3 (difficult - inadequate or unstable or requiring
two care providers, with or without NMBDs). As a re-
sult, small, but potentially relevant differences in mask
ventilation conditions are difficult to quantify. In con-
trast, the Warters grading scale is a composite score
based on the ability to achieve a target tidal volume of 5
ml.kg−1 [11]. Points are awarded based on the need for a
NPA, OPA, second operator, increasing PIPs, or tidal
volumes < 5 ml.kg−1. Our observation that patients, on
average, received greater tidal volumes with lower PIPs
after administration of NMBDs provides the most plaus-
ible explanation for the significant decrease in Warters
scores between the two measurement periods.
Irrespective of which definition used, overall, patients
who were difficult to ventilate achieved statistically
greater tidal volumes following the administration of a
NMBD. On average, the increase in exhaled volumes
was 46–110 ml. As noted by other investigators [13], this
increase should not be discounted solely as one of statis-
tical relevance. Based on a respiratory rate of 15 breaths/
min, as we suggested in our study, minute ventilation
would increase by 690–1650 ml/min, an amount that is
greater than two-times the average oxygen consumption
in an otherwise healthy patient [16]. Thus, we conclude
that this difference is clinically relevant.
We acknowledge that our study has limitations. We
employed convenience sampling, which could have in-
troduced selection bias. The only portion of the study
Table 4 Comparison of selected outcomes of face mask ventilation before and after administration of neuromuscular blocking
drugs. Data presented as mean (SD), median (IQR [range]), or number (%)
Before After Mean difference (95 % CI) p-valuea,b
Vt, ml.breath−1 399 (169) 428 (166) 30 (12, 47) 0.001
PIP, cmH2O 19 (5.5) 17 (3.4) −1.7 (−1, −2.4) <0.001
Breaths delivered 14 (2.2) 15 (1.5) — <0.001
VE, l.min
−1 5.6 (2.5) 6.3 (2.5) 0.6 (0.4, 0.9) <0.001
Han scale 1 (1-2 [1–4]) 1 (1-2 [1–4]) — 0.11
Warters scale 5 (0-6 [0–10]) 2 (0-5 [0–9]) −0.7 (−0.4, −1) <0.001
MVi or Vds 35 (16.6) 27 (12.8) — 0.20
Predicted body weight based on height in inches and gender from National Heart, Lung and Blood Institute Acute Respiratory Distress Syndrome Network
formula, which can be accessed at http://www.ardsnet.org/files/pbwtables_2005-02-02.pdf
aComparisons made by paired t-test or Wilcoxon signed rank test for normally and non-normally distributed paired continuous data, respectively. Mean difference
displayed for normally distributed continuous data only.bComparison made by McNemar’s test for paired proportions of binomial data
Vt tidal volume, PIP peak inspiratory pressure, CI confidence interval, SD standard deviation, VE minute ventilation, MVi inadequate mask ventilation (<4 ml.kg
−1
predicted body weight), Vds dead-space ventilation (<150 ml, no clinical sign of ventilation)
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aesthetic induction and administration of the NMBD.
Positioning of the airway and the use of airway adjuncts
to maximise upper airway patency were left to the dis-
cretion of the primary anaesthesia providers. Also, as
already stated, a standard airway pressure profile
throughout the respiratory cycle, as would be the case
when using the mechanical ventilator of the anaesthesia
machine in pressure control mode, was not provided.
Thus, some of the differences observed between study
periods could be independent of the effects from the
NMBDs. While study methods standardising every as-
pect of airway managment may have been more scientif-
ically valid, we believe the generalisability to routine
anaesthetic practice would have been severely limited.
Using mechanically generated breaths from the anaes-
thesia ventilator rather than the breathing bag is much
less common. It should also be noted that the most
commonly used FMV grading scale, the Han scale [14],
was derived from patients who were hand ventilated.
The same is true of the Warter’s scale [11]. Furthermore,
the most widely cited studies on the incidence of DMV,
IMV, DMV/IMV, or DMV combined with difficult laryn-
goscopy are reporting on patients who were hand venti-
lated after the induction of anaesthesia [1–4, 17].
Regarding the use of each patient as there own con-
trol, we cannot know what would have happened to
the tidal volumes over time without the NMBDs.Table 5 Comparison of tidal volumes before and after administratio
graded as difficult face mask ventilation
N Before
Han score ≥3 32 350 (170)
Warters score ≥4 119 320 (130)
Vt < 4 ml.kg−1 PBW or <150 ml 39 170 (74)
*Comparisons made by paired t-test
Vt tidal volume, PBW Predicted body weightFMV may improve over time due to deepening in the
plane of anaesthesia. In our study anaesthesia was in-
duced intravenously using propofol with or without
the concomitant administration of fentanyl. While we
did assess depth of anaesthesia clinically prior to initi-
ating FMV, we did not employ specific depth of an-
aesthesia monitoring. Thus, we cannot exclude the
possibility that some of the DMV we observed was a
result of a suboptimal depth of anaesthesia. Addition-
ally, uncontrolled adjustments in airway positioning
made by the operator to optimise ventilation may
have also improved FMV even without administration
of NMBDs. This limitation could be overcome by
randomising patients to receive a NMBD or placebo
after the initial, post-induction measurments are re-
corded. However, our primary goal was to demonstrate
that in any individual patient, the administration of a
NMBD would not turn a DMV scenario into one where
ventilation is not possible. Thus, we believe our study de-
sign, where the use of NMBDs is within the context of
routine anaesthetic practice, is justified.
In the operating room, DMV is uncommon (<1.5 per
100 mask ventilations [3]) and IMV is rare (1.5 per 1000
mask ventilations [4]). The combined incidence of DMV
and one of the following: inability to intubate by DL, DL
with a bougie introducer, or videolaryngoscopy is rare
(0.04 % or 1 per 2,500 anaesthetics [17]). Even so, the in-
cidence of DMV or DMV combined with DL has beenn of neuromuscular blocking drugs in patients who were initially
After Mean difference (95 % CI) p-value*
430 (200) 77 (26, 130) 0.004
370 (130) 46 (26, 70) <0.001
290 (120) 110 (69, 150) <0.001
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ministered a NMBD [17]. It has been noted that a major
limitation of the studies just mentioned is that they are
based on large observational datasets extracted from the
electronic medical record. Thus, the specific timing and
effect of any administered NMBDs cannot be specifically
examined. As a result, controlled experiments specific-
ally designed to assess the impact of NMB on DMV are
needed [17]. While our study was not large enough to
document equivalence for an outcome of “cannot-intub-
ate, cannot ventilate,” it is the largest to date within the
context of other similar studies [11–13]. Importantly, al-
though we found that FMV did degrade in some pa-
tients, none became impossible to ventilate and all were
easily intubated. This adds to the literature, which sup-
ports, but does not confirm the safety of giving NMBDs
at the outset of anaesthetic induction in patients where
tracheal intubation is planned to optimise intubating
conditions. Lastly, the reader is cautioned not be general-
ise our results to patients not represented by our study
population. In particular, children, parturients and true
difficult intubations were not studied.
Conclusion
We set out to show that FMV before and after the admin-
istration of a NMBD would not, on average, cause a de-
crease in delivered tidal volumes greater than an a priori
defined equivalence limit of 50 mL. We found that in our
study population of elective surgical patients, half of
whom exhibited multiple risk factors for DMV and a quar-
ter of whom had a BMI >32 kg.m−2, the administration of
NMBD did not make FMV worse. In fact, the administra-
tion of a NMBD was more likely than not to facilitate
FMV. Furthermore, only 3 patients required a third intub-
ation attempt, none of who were difficult to mask venti-
late. Thus, routinely “testing” the operators’ ability to
ventilate the patient by mask prior to the administration
of a NMBD would appear to provide little diagnostic in-
formation. However, anaesthesiologists must still use their
best judgment in integrating their individual skills set and
the patient’s airway characteristics when deciding on the
the best course of action.
Endnotes
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